Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 158

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Prognostic Role of Overt Hypercortisolism in Completely Operated Patients with Adrenocortical Cancer

Open access
Berruti, Alfredo, Fassnacht, Martin, Haak, Harm, Else, Tobias, Baudin, Eric, Sperone, Paola, Kroiss, Matthias, Kerkhofs, Thomas, Williams, Andrew R., Ardito, Arianna, Leboulleux, Sophie, Volante, Marco, Deutschbein, Timo, Feelders, Richards, Ronchi, Cristina, Grisanti, Salvatore, Gelderblom, Hans, Porpiglia, Francesco, Papotti, Mauro, Hammer, Gary D., Allolio, Bruno, Terzolo, Massimo · 2014 · European Urology

Abstract

BACKGROUND Although prognostic parameters are important to guide adjuvant treatment, very few have been identified in patients with completely resected adrenocortical carcinoma (ACC). OBJECTIVE To assess the prognostic role of clinical symptoms of hypercortisolism in a large series of patients with completely resected ACC. DESIGN, SETTING, AND PARTICIPANTS A total of 524 patients followed at referral centers for ACC in Europe and the United States entered the study. Inclusion criteria were ≥18 yr of age, a histologic diagnosis of ACC, and complete surgery (R0). Exclusion criteria were a history of other malignancies and adjuvant systemic therapies other than mitotane. INTERVENTION All ACC patients were completely resected, and adjuvant mitotane therapy was prescribed at the discretion of the investigators. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS The primary end point was overall survival (OS). The secondary end points were recurrence-free survival (RFS) and the efficacy of adjuvant mitotane therapy according to cortisol secretion. RESULTS AND LIMITATIONS Overt hypercortisolism was observed in 197 patients (37.6%). Patients with cortisol excess were younger (p=0.002); no difference according to sex and tumor stage was observed. The median follow-up of the series was 50 mo. After adjustment for sex, age, tumor stage, and mitotane treatment, the prognostic significance of cortisol excess was highly significant for both RFS (hazard ratio [HR]: 1.30; 95% confidence interval [CI], 1.04-2.62; p=0.02) and OS (HR: 1.55; 95% CI, 1.15-2.09; p=0.004). Mitotane administration was associated with a reduction of disease progression (adjusted HR: 0.65; 95% CI, 0.49-0.86; p=0.003) that did not differ according to the patient's secretory status. A major limitation is that only symptomatic patients were considered as having hypercortisolism, thus excluding information on the prognostic role of elevated cortisol levels in the absence of a clinical syndrome. CONCLUSIONS Clinically relevant hypercortisolism is a new prognostic factor in patients with completely resected ACC. The efficacy of adjuvant mitotane does not seem to be influenced by overt hypercortisolism.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.eururo.2013.11.006

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 158

Metadata

Authors
Berruti, A., Fassnacht, M., Haak, H., Else, T., Baudin, E., Sperone, P., Kroiss, M., Kerkhofs, T., Williams, A. R., Ardito, A., Leboulleux, S., Volante, M., Deutschbein, T., Feelders, R., Ronchi, C., Grisanti, S., Gelderblom, H., Porpiglia, F., Papotti, M., Hammer, G. D., Allolio, B., & Terzolo, M.
Venue
European Urology
Publisher
Elsevier BV
Published
2014-04
Volume
65
Issue
4
Pages
832-838
ISSN
0302-2838 (ISSN-L)
OpenAlex
W2010908714
Cited by
158
References
6
FWCI
8.08
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prognostic Role of Overt Hypercortisolism in Completely Operated Patients with Adrenocortical Cancer. https://app.cochat.ai/papers/10.1016/j.eururo.2013.11.006
The paper
Berruti, A., Fassnacht, M., Haak, H., Else, T., Baudin, E., Sperone, P., Kroiss, M., Kerkhofs, T., Williams, A. R., Ardito, A., Leboulleux, S., Volante, M., Deutschbein, T., Feelders, R., Ronchi, C., Grisanti, S., Gelderblom, H., Porpiglia, F., Papotti, M., . . . Terzolo, M. (2014). Prognostic Role of Overt Hypercortisolism in Completely Operated Patients with Adrenocortical Cancer. European Urology. https://doi.org/10.1016/j.eururo.2013.11.006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.